Add BrightSurf on Google Email

SARS-CoV-2 jumped from bats to humans without much change

The study found that SARS-CoV-2 underwent little significant genetic change in the first year of the pandemic, suggesting a 'generalist' nature and rapid transmission. This is attributed to human population immunity and lack of containment, allowing the virus to spread quickly.

SourcePLOS·JournalPLOS Biology·DateMar 12, 2021

Second shot of COVID-19 vaccine may not be necessary in previously infected individuals -- Mount Sinai

Researchers at Mount Sinai found that a single shot of COVID-19 vaccine can provide immunity to individuals who have previously been infected by the virus. This could help stretch limited vaccine supplies and spare individuals from unnecessary side effects of a second dose.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalNew England Journal of Medicine·DateMar 10, 2021

More than 2/3 of Indiana nursing home staff would take COVID-19 vaccine

A survey of over 8,000 nursing home and assisted living staff in Indiana found that 45% would take a vaccine as soon as it was available, while an additional 24% said they would take it at some point in the future. Concerns about side effects, health risks, and effectiveness were common reasons for not wanting to receive the vaccine.

SourceRegenstrief Institute·JournalJournal of the American Geriatrics Society·DateMar 8, 2021

Goodbye UTIs: Duke scientists develop vaccine strategy for urinary tract infections

Researchers at Duke University Medical Center have developed a new vaccination strategy to prevent urinary tract infections (UTIs). In tests in mice, the vaccine administered directly to the bladder effectively cleared bacteria. The study suggests that reprogramming the body's immune response could be key to fighting off UTIs.

SourceDuke University Medical Center·JournalProceedings of the National Academy of Sciences·DateMar 1, 2021

New discoveries on the containment of COVID-19 finds travel bans are of limited value

A new study published in the Journal of the Royal Society Interface suggests that reducing individual activity through social distancing is far superior in controlling the dissemination of Sars-CoV-2. The research found that limiting personal mobility through travel restrictions and similar tactics is effective only in the first phases...

SourceNYU Tandon School of Engineering·JournalJournal of The Royal Society Interface·DateFeb 24, 2021

What to do when a mammogram shows swollen lymph nodes in women just vaccinated for COVID

Radiologists at Massachusetts General Hospital have developed an approach to manage swollen lymph nodes on mammograms in women who have recently received COVID-19 vaccinations. The approach aims to reduce delays in vaccinations and breast cancer diagnoses while reassuring patients that the swelling is a normal response to vaccination.

SourceMassachusetts General Hospital·JournalAmerican Journal of Roentgenology·DateFeb 24, 2021

International study finds increased COVID-19 mortality among adults with Down syndrome

A new study found adults with Down syndrome are roughly three times more likely to die from COVID-19 than the general population. The study's results have implications for preventive and clinical management of COVID-19 patients with Down syndrome, highlighting the need to prioritize individuals with this genetic condition for vaccination.

SourceCase Western Reserve University·JournalEClinicalMedicine·DateFeb 22, 2021

An mRNA vaccine for cancer immunotherapy

Researchers have developed a hydrogel that slowly releases mRNA nanoparticles, activating T cells and stimulating antibody production in mice with melanoma. The treatment causes tumors to shrink and prevents metastasis, demonstrating great potential for long-lasting cancer immunotherapy.

SourceAmerican Chemical Society·JournalNano Letters·DateFeb 17, 2021

Most European countries ignore patients with severe mental illness in COVID vaccine strategy

A survey of 20 European countries found that only 4 prioritize COVID vaccinations for individuals with severe mental disorders. The authors call for coordinated action to protect these vulnerable patients. Many countries do not mention mental health in their vaccination priority guidance, leaving patients at risk.

SourceEuropean College of Neuropsychopharmacology·JournalThe Lancet Psychiatry·DateFeb 17, 2021

The Lancet: COVID-19 vaccination potential will not be achieved without increased production, affordable pricing, global availability, and successful rollout

To ensure an effective global immunization strategy against COVID-19, vaccines must be produced at scale, priced affordably, and allocated globally. The authors assess the potential contribution of leading vaccines using a traffic light system, highlighting production challenges and the need for equitable distribution. Governments and ...

SourceThe Lancet·JournalThe Lancet·DateFeb 12, 2021

One dose of COVID-19 vaccine provokes strong immune response in those previously infected

A recent study published in Eurosurveillance found that one dose of the Pfizer vaccine triggers a strong immune response in people who have previously been infected with SARS-CoV-2. The researchers also observed similar responses across multi-ethnic groups, suggesting that vaccination priority for those previously infected may not be n...

SourceBar-Ilan University·JournalEurosurveillance·DateFeb 11, 2021

Rabies treatment demonstrated as safe and effective for use in children in first pediatric trial

Researchers have demonstrated a new treatment called KEDRAB to be safe and effective for use in children with rabies, marking the first pediatric trial of any human rabies immunoglobulin currently available in the US. The study found no deaths or serious adverse events among participants, and most side effects were mild.

SourceTaylor & Francis Group·JournalHuman Vaccines & Immunotherapeutics·DateFeb 10, 2021

Vaccine confidence grows under new administration, latest CUNY SPH Survey reveals

New Yorkers' acceptance of the Covid-19 vaccine has significantly increased under the Biden Administration, with 64% reporting they would take it in January, up from 55% in September. Disparities persist across racial and ethnic groups, but the largest increase was seen among Black respondents. The survey also found that employed indiv...

SourceCUNY Graduate School of Public Health and Health Policy·JournalJournal of Health Communication·DateFeb 9, 2021

Making good decisions about COVID-19

Researchers David Rode and Paul Fischbeck argue that decision sciences can play a crucial role in addressing the COVID-19 pandemic. They emphasize the importance of collecting accurate data on population infection rates to inform decision-making and policy development.

SourceCarnegie Mellon University·JournalRisk Analysis·DateFeb 9, 2021

Story tips from Johns Hopkins experts on Covid-19

A commentary by Johns Hopkins experts highlights the need for standardized data collection and analysis to inform policy decisions and strategies. They propose creating a consensus task force to define metrics and refine them over time, enabling public health leaders and healthcare organizations to identify effective solutions.

SourceJohns Hopkins Medicine·JournalJournal of Hospital Medicine·DateFeb 9, 2021